Role of extracellular signal-regulated kinases in angiotensin II- stimulated contraction of smooth muscle cells from human resistance arteries

Circulation

Volumn 99, Issue 3, 1999, Pages 392-399

  Touyz, Rhian M ^a   He, Gang ^a   Deng, Li Yuan ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin; Arteries; Calcium; Kinases; Signal transduction

Indexed keywords

ARTICLE; CELL GROWTH; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERTENSION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0032890562     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.3.392     Document Type: Article

References (48)

1. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-736.
2. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
3. Sauro MD, Sudakow R, Burns S. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine kinase-dependent mechanism. J Pharmacol Exp Ther. 1996;277:1744 -1750.
4. Timmermans PMWM, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens. 1992;5(pt 2):221S-235S.
5. Griendling KK, Ushio-Fukai M, Lassègue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle: new concepts. Hypertension. 1997;20(pt 2):366-373.
6. 2+-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype. Circ Res. 1996;78:962-970.
7. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31(part 2): 152-161.
8. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G-protein-coupled receptors. Cell Signal. 1997;9: 337-351.
9. Touyz RM, Schiffrin EL. Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium transients in vascular smooth muscle cells. Hypertension. 1996;27:1097-1103.
10. Kruse HJ, Bauriedel G, Heimerl J, Hofling B, Weber PC. Role of L-type calcium channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells. J Cardiovasc Pharmacol. 1994;24:328-335.
11. Patel MK, Betteridge LJ, Hughes AD, Clunn DG, Schachter M, Shaw RJ, Sever PDS. Effect of angiotensin II on the expression of the early growth response gene c-fos and DNA synthesis in human vascular smooth muscle cells. J Hypertens. 1996;14:341-347.
12. Takagishi T, Murahashi N, Azagami S, Morimatsu M. Sasaguri Y. Effect of angiotensin II and thromboxane A2 on the production of matrix metalloproteinase by human aortic smooth muscle cells. Biochem Mol Biol Int. 1995;35:265-273.
13. Yazawa H, Iida-Kubota E, Honda K. Human aortic smooth muscle cells containing angiotensin II type I receptors. Jpn J Pharmacol. 1993;62: 339-343.
14. Cox BE, Word RA, Rosenfeld CR. Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J Clin Endocrinol Metab. 1996;81:49-58.
15. Hatakeyama H, Miyamori I, Yamagishi S, Takeda Y, Takeda R, Yamamoto H. Angiotensin II upregulates the expression of type A endothelin receptor in human vascular smooth muscle cells. Biochem Mol Biol Int. 1994;34:127-134.
16. Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension. 1995;25:913-917.
17. Svane D, Kahr O, Hansen VB, Holm-Nielsen P, Formar A. Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries. Am J Obstet Gynecol. 1995;172: 991-997.
18. Schiffrin EL, Deng LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med. 1993;16:177-186.
19. Davis MJ, Ferrer PN, Gore RW. Vascular anatomy and hydrostatic pressure profile in the hamster cheek pouch. Am J Physiol. 1986;250(pt 2):H291-H303.
20. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res. 1993;30: 73-79.
21. Joyner WL, Davis MJ. Pressure profile along the microvascular network and its control. Fed Proc. 1987;46:266-269.
22. Schiffrin EL, Poissant L, Cantin M. Thibault G. Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells. Life Sci. 1986;38:817-826.
23. Touyz RM, Tolloczco B, Schiffrin EL. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II, but not to endothelin-1. Hypertension. 1994;12:663-673.
24. Li X, Tsai P, Wieder ED, Kribben A, Putten VV, Schrier RW, Nemenoff RA. Vascular smooth muscle cells grown on matrigel: a model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem. 1994;269:19653-19658.
25. 2+ indicators with greatly improved fluorescent properties. J Biol Chem. 1985; 260:3440-3450.
26. Kahn AM, Bishara M, Cragoe EJ Jr, Allen JC, Seidel CL, Navran SS, O'Neil RG, McCarty NA, Shelat H. Effects of serotonin on intracellular pH and contraction in vascular smooth muscle. Circ Res. 1992;71:1294-1304.
27. Touyz RM, Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine-kinase dependent signaling pathways. Hypertension. 1997;30:222-229.
28. Bodin P. Travo C, Stoclet J-C, Travo P. High sensitivity of hypertensive aortic myocytes to norepinephrine and angiotensin. Am J Physiol. 1993; 264:C441-C445.
29. Bolzon JB, Cheung DW. Isolation and characterization of single vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1989;14:137-144.
30. Thomas JH, Buchbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cell utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:2210-2218. inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
31. Thomas JH, Buchbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cell utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:2210-2218. inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
32. Pang L, Sawada T, Decker SJ, Saltiel AR, Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.
33. Dudley DT. Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
34. Berridge MJ. Spatial and temporal signaling by calcium. Curr Opin Cell Biol. 1994;6:267-274.
35. Wray S. Smooth muscle intracellular pH: measurement, regulation and function. Am J Physiol. 1988;254:C751-C758.
36. - -dependent mechanism. Circ Res. 1990;67:814-825.
37. Carr P, McKinnon W, Poston L. Mechanisms of pH, control and relationships between tension and pH, in human subcutaneous small arteries. Am J Physiol. 1995;268:C580-C589.
38. Izzard AS, Cragoe EJ, Heagerty AM. Intracellular pH in human resistance arteries in essential hypertension. Hypertension. 1991;17:780-786.
39. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the PP44 and PP42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
40. Takahashi T, Kawahara Y, Okuda W, Ueno H, Takeshita A, Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem. 1997;272:16018-16022.
41. Jin N, Siddiqui RA, English D, Rhoades RA. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol. 1996;271:H1348-H1355.
42. Pelech SL, Sanghora JS. MAP kinases: charting the regulatory pathways. Science. 1992;257:1355-1356.
43. Robinson MJ. Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
44. Liao D-F, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase activity in vascular smooth muscle cells: role of Raf. Circ Res. 1996;79:1007-1014.
45. Berk BC, Corson MA. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 1997;80:607-616.
46. Goutsouliak V, Rabkin SW. Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes. Cell Signal. 1997;9:505-512.
47. Wijetunge S, Aalkjaer C, Schachter M, Hughes AD. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun. 1992;189:1620-1623.
48. Adam LP, Franklin MT, Raff GJ, Hathaway DR. Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ Res. 1995;76:183-190.